The historical background of hereditary cystatin C amyloid angiopathy: Genealogical, pathological, and clinical manifestations
Brain Pathology · 2025-03 · 35 (2)
DOI: 10.1111/bpa.13291 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain Pathology, online erschienen am 25.07.2024. Verfasst von Asbjorg Osk Snorradottir und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Iceland, Reykjavik, Iceland. Hauptthemen laut MEDLINE: Cystatin C, Cerebral Amyloid Angiopathy, Cerebral Amyloid Angiopathy, Familial. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Hereditary cystatin C amyloid angiopathy (HCCAA) is an Icelandic disease that belongs to a disease class called cerebral amyloid angiopathy, a group of heterogenous diseases presenting with aggregation of amyloid complexes and deposition predominantly in the central nervous system. HCCAA is dominantly inherited, caused by L68Q mutation in the cystatin C gene, leading to aggregation of the cystatin C protein. HCCAA is a very progressive and severe disease, with widespread cerebral and parenchymal cystatin C and collagen IV deposition within the central nervous system (CNS) but also in other organs in the body, for example, in the skin. Most L68Q carriers have clinical symptoms characterized by recurrent hemorrhages and dementia, between the age of 20–30 years. If the carriers survive the first hemorrhage, the frequency and severity of the hemorrhages tend to increase, resulting in death at average of 30 years with mean number of major hemorrhages ranging from 3.2 to 3.9 over a 5‐year average life span. The pathogenesis of the disease in carriers is very similar in the CNS and in the skin based on autopsy studies, thus skin biopsies can be used to monitor the progression of the disease by quantifying the cystatin C immunoreactivity. The cystatin C deposition always colocalizes with collagen IV and fibroblasts in the skin are found to be the main cell type responsible for the deposition of both proteins. No therapy is available for this devastating disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
- Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland.
- Center for Applied Genomics, Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Department of Pediatrics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Asbjorg Osk Snorradottir
Zitieren
APA
Snorradottir, A. O., Hakonarson, H., & Palsdottir, A. (2025). The historical background of hereditary cystatin C amyloid angiopathy: Genealogical, pathological, and clinical manifestations. Brain Pathology, 35(2). https://doi.org/10.1111/bpa.13291
Vancouver
Snorradottir AO, Hakonarson H, Palsdottir A. The historical background of hereditary cystatin C amyloid angiopathy: Genealogical, pathological, and clinical manifestations. Brain Pathology. 2025;35(2). doi:10.1111/bpa.13291
BibTeX
@article{Snorradottir2025,
author = {Snorradottir, Asbjorg Osk and Hakonarson, Hakon and Palsdottir, Astridur},
title = {The historical background of hereditary cystatin C amyloid angiopathy: Genealogical, pathological, and clinical manifestations},
journal = {Brain Pathology},
year = {2025},
volume = {35},
number = {2},
doi = {10.1111/bpa.13291}
}
EUVIMED